Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

A

ATOS

Atossa Therapeutics Inc

2.54

Aug 21 • 3:59 PM ET -0.05 (-1.93%)

2.57

Aftermarket • 7:56 PM ET +0.03 (1.18%)

Healthcare Biotechnology USA Nano NASD

Peers: KPTI RNTX XLO GLSI INDP OTLK TARA PALI PRLD RZLT

| Held by: VTI VXF IWC

Scroll to Statements

Index	-
Market Cap	25.35M
Enterprise Value	-0.85M
Income	-37.71M
Sales	0.00M
Book/sh	2.69
Cash/sh	2.63
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	14
IPO	Nov 08, 2012

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	0.94
P/C	0.97
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	5.69
Current Ratio	5.69
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-4.34
EPS next Y	-2.52
EPS next Q	-0.90
EPS this Y	4.95%
EPS next Y	34.24%
EPS next 5Y	-
EPS past 3/5Y	-8.13% 32.87%
Sales past 3/5Y	- -
EPS Y/Y TTM	-28.83%
Sales Y/Y TTM	-
EPS Q/Q	2.57%
Sales Q/Q	-
Earnings	Aug 07 BMO
EPS/Sales Surpr.	7.32% -

Insider Own	1.52%
Insider Trans	0.00%
Inst Own	13.49%
Inst Trans	1.10%
ROA	-77.91%
ROE	-89.23%
ROIC	-140.55%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	4.99%
SMA50	10.29%
SMA200	-58.16%
Trades

Shs Outstand	9.98M
Shs Float	9.83M
Short Float	7.73%
Short Ratio	4.88
Short Interest	0.76M
52W High	19.35 -86.87%
52W Low	1.70 49.41%
Volatility	8.99% 7.65%
ATR (14)	0.20
RSI (14)	51.69
Beta	1.27
Rel Volume	0.16
Avg Volume	155.83K
Volume	25,656

Perf Week	-2.31%
Perf Month	5.39%
Perf Quarter	-48.89%
Perf Half Y	-39.67%
Perf YTD	-71.30%
Perf Year	-77.24%
Perf 3Y	-81.53%
Perf 5Y	-94.81%
Perf 10Y	-99.63%
Recom	1.00
Target Price	14.33
Prev Close	2.59
Price	2.54
Change %	-1.93%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)